Royal Bank of Canada
ONCT

Royal Bank of Canada’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Royal Bank of Canada’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$3K – 7799
2023
Q3 		$3K Buy
500
+436
+681% +$3.07K ﹤0.01% 6751
2023
Q2 		$0 Buy
+64
New +$422 ﹤0.01% 7848
2022
Q2 		– Sell
-136
Closed -$4K – 7894
2022
Q1 		$4K Sell
136
-318
-70% -$11.6K ﹤0.01% 7352
2021
Q4 		$21K Buy
454
+170
+60% +$11.4K ﹤0.01% 6793
2021
Q3 		$23K Buy
284
+132
+87% +$10.9K ﹤0.01% 6643
2021
Q2 		$14K Buy
152
+52
+52% +$6.17K ﹤0.01% 6753
2021
Q1 		$17K Sell
100
-2
-2% -$265 ﹤0.01% 6536
2020
Q4 		$10K Buy
+102
New +$6.45K ﹤0.01% 6391
2020
Q1 		– Hold
0
– – – 7143
2019
Q4 		– Hold
0
– – – 7219
2019
Q3 		– Hold
0
– – – 7254
2019
Q2 		– Hold
0
– – – 7291
2018
Q4 		– Hold
0
– – – 7242
2018
Q3 		– Hold
0
– – – 7035
2018
Q1 		– Hold
0
– – – 6921
2017
Q4 		– Hold
0
– – – 7003
2017
Q3 		– Hold
0
– – – 7070
2016
Q3 		– Hold
0
– – – 6630
2016
Q2 		– Hold
0
– – – 6574
2015
Q4 		– Hold
0
– – – 6881
2015
Q3 		– Hold
0
– – – 6833
2015
Q2 		– Hold
0
– – – 6766
2015
Q1 		– Hold
0
– – – 6474
2014
Q4 		– Hold
0
– – – 6338
2013
Q4 		– Hold
0
– – – 6205
2013
Q3 		– Hold
0
– – – 6308

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $786M AUM 19.96% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Royal Bank of Canada's ONCT Position: Q4 2023 in Review

Royal Bank of Canada sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q4 2023, closing a stake of 500 shares — an estimated $3K sold.

Royal Bank of Canada first reported a position in ONCT in Q4 2020 and held it in 8 quarters. The position peaked at $23K in Q3 2021. 38 funds tracked by Wall St. Rank hold ONCT as of Q4 2023.

  • Royal Bank of Canada reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 500 Oncternal Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $3K.
  • Royal Bank of Canada first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Royal Bank of Canada's Oncternal Therapeutics, Inc. Common Stock position peaked at $23K in Q3 2021.
  • 38 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.